Roche Diagnostics Named To 2017 Working Mother "100 Best Companies" For Leadership In Family Benefits And Paid Leave
NEW YORK, Sept. 26, 2017 /PRNewswire/ -- Working Mother magazine today recognized Roche Diagnostics as one of the 2017 Working Mother 100 Best Companies for its strong leadership in creating progressive programs for its workforce in the areas of advancement of women, flexibility, childcare and paid parental leave. The 100 Best Companies are featured in the October/November issue of Working Mother and on workingmother.com.
"We are proud to be recognized once again for offering best-in-class benefits and programs that meet the evolving needs of our working moms and their families," said Bridget Boyle, VP and Site Head, Human Resources, Roche Diagnostics. "Our employees are our most important asset and it's important they feel valued and supported."
Working Mother Editor-in-Chief Meredith Bodgas says, "This year's winning companies know the value of keeping their employee moms engaged and supported. They use schedule flexibility, paid parental leave and family benefits to ensure that parents can develop meaningful careers while leading satisfying home lives."
Subha Barry, senior vice president & managing director of Working Mother Media, says, "As our 32nd year of recognizing the best companies begins, we are happy to see that the next generation, coupled with technology, have shown us how employees can be efficient, productive, effective and impactful no matter where they work. The 2017 Working Mother 100 Best Companies' policies and programs have built loyalty among their employees that cannot be underestimated."
The complete list of the 2017 Working Mother 100 Best Companies can be found here.
Here are highlights from the "Best vs. Rest"* data from Working Mother Media:
- 100% of the 2017 100 Best Companies offer paid maternity leave vs. 30% on a national scale; 97% offer paid paternity leave vs. 24% of U.S. companies. *
- A full 100% of the 100 Best Companies offer flextime for employees vs. 57% nationally.
* Source: Society for Human Resource Management (SHRM) report 2017 Employee Benefits.
About Working Mother Media
Working Mother Media (WMM), a division of Bonnier Corporation (bonniercorp.com), publishes Working Mother magazine and its companion website, workingmother.com. The Working Mother Research Institute (workingmother.com/wmri), the National Association for Female Executives (nafe.com) and Diversity Best Practices (diversitybestpractices.com) are also units within WMM. WMM's mission is to serve as a champion of culture change. Working Mother magazine is the only national magazine for career-committed mothers. Follow us on Facebook, Twitter, LinkedIn, Instagram and Pinterest.
About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognized as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices (DJSI).
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide. In 2016, Roche invested CHF 9.9 billion in R&D and posted sales of CHF 50.6 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com or usdiagnostics.roche.com.
All trademarks used or mentioned in this release are protected by law.
For further information, please contact:
Carole Puls, [email protected], 317-829-4827
Working Mother Contact:
Andrea Kaplan, [email protected], 917-836-2741
SOURCE Roche Diagnostics
Share this article